Project Grant R35GM163868
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $390,000 through its Biomedical Research and Research Training program (CFDA 93.859) to the University of Texas Health Science Center at Houston for a Project Grant commencing March 1, 2026, and concluding December 31, 2030. This award funds basic biomedical research investigating inter-organelle unfolded protein response (UPR) coordination and cellular proteostasis—specifically examining how cells...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $429,000 Project Grant to the University of Texas Health Science Center at Houston under the Biomedical Research and Research Training program (CFDA 93.859) on March 6, 2026, with a performance period extending through February 28, 2031. This award funds fundamental research into the mechanisms regulating endoplasmic reticulum-selective autophagy (ER-phagy) during cellular stress conditions. The...
- Federal Project Grant Award Summary The University of Texas Health Science Center at Houston received a $670,800 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through May 31, 2029. The award supports fundamental research investigating the synthesis, trafficking, and regulation of phosphatidylserine (PS) in cellular cholesterol homeostasis. The research will...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $449,900 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded May 1, 2026, with completion expected by April 30, 2028. This exploratory research project develops novel methods to detect and quantify multi-site protein phosphorylation—a critical post-translational modification affecting nearly...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Cornell University a $258,713 Project Grant on July 1, 2026, through the Biomedical Research and Research Training program (CFDA 93.859) to support fundamental research on phospholipid homeostasis mechanisms in eukaryotic cells. The research program, directed from Cornell's Ithaca, NY campus and extending through June 30, 2031, focuses on deciphering how cells regulate the biosynthesis and...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Massachusetts Institute of Technology (MIT) $438,788 in federal funding under the Biomedical Research and Research Training program (CFDA 93.859) beginning July 1, 2026 and concluding June 30, 2031. The project, titled "Microbial Manipulation of Eukaryotic Membranes," will deliver fundamental research findings on how pathogenic bacteria manipulate host cell membrane trafficking and...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Texas at Arlington $412,433 through the Biomedical Research and Research Training program (CFDA 93.859) effective March 1, 2026, with a completion date of January 31, 2031. This Project Grant funds fundamental research investigating bacterial stress response mechanisms mediated by cyclic di-adenosine monophosphate (c-di-AMP), a secondary messenger molecule produced by over...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Harvard College's Office for Sponsored Programs a $508,111 Project Grant (CFDA 93.859: Biomedical Research and Research Training) effective May 1, 2026, through February 28, 2031. The award supports investigator-initiated basic research focused on uncovering the molecular mechanisms and selectivity determinants of bacterial membrane proteins that mediate critical cellular processes including...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Texas A&M University System Health Science Center a Project Grant of $420,657 under the Biomedical Research and Research Training program (CFDA 93.859) to support investigator-initiated basic research. The award, effective July 1, 2026, and concluding March 31, 2031, funds research into nanoscale structure and dynamics within nuclear pores and biomolecular condensates. The research...
- Federal Project Grant Award Summary Texas A&M Agrilife Research received an $832,796 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. The grant funds fundamental research into the mechanisms and regulation of neutral lipid metabolism, specifically investigating how cells produce and control the synthesis of triacylglycerols and sterol...
The National Institute of General Medical Sciences (NIGMS) awarded a $429,000 Project Grant to the University of Texas Health Science Center at Houston for basic biomedical research on membrane phospholipid homeostasis in microorganisms. Funded through the Biomedical Research and Research Training program (CFDA 93.859), the award commenced on August 1, 2026, and extends through March 31, 2031. The research investigates the structural organization and regulatory mechanisms of phospholipid metabolic enzyme complexes (metabolons) in Escherichia coli, with particular focus on how these metabolic networks integrate with cellular division machinery and redox homeostasis. The project delivers fundamental scientific discoveries through coordinated biochemical and biophysical research, including bacterial two-hybrid screening, biolayer interferometry, crosslinking mass spectrometry, and phospholipid radiolabeling analysis. Specifically, the research aims to define the organization and regulatory mechanisms of the phospholipid metabolon, elucidate its interplay with divisome complexes to coordinate membrane biogenesis with cell division, and determine the structural basis of redox-regulated enzymatic functions. These findings will advance understanding of bacterial membrane dynamics and establish foundational knowledge applicable to bacterial physiology, envelope integrity, and potential therapeutic interventions targeting membrane-associated processes.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $429.0k | 7/8/26 |